雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

A case illustrating the complications associated with cosmetic artificial iris implantation Saki Domoto 1 , Nobutaka Tachibana 1 , Tomoyuki Yamazaki 1 , Akari Arakawa 1 , Masakazu Takayama 1 , Tomoki Endo 1 , Yoshihiro Hotta 1 1Department of Ophthalmology, Hamamatsu University School of Medicine pp.790-796
Published Date 2025/6/15
DOI https://doi.org/10.11477/mf.037055790790060790
  • Abstract
  • Look Inside
  • Reference

Abstract Purpose:This report presents the case of a patient who underwent bilateral BrightOcular®(Stellar Devices)artificial iris implantation overseas and developed multiple complications and severe visual impairment 17 years postoperatively. The long-term complications associated with artificial iris implantation for cosmetic purposes are also discussed.

Case:A 41-year-old man who underwent bilateral artificial iris implantation in Turkey in 2006 presented to our department in 2022 with decreased vision and pain in the left eye. Initial examination revealed corrected visual acuity of 1.2 and 0.15 in the right and left eyes, respectively. The intraocular pressure was 16 mmHg in both eyes. The corneal endothelial cell count was 1,304/mm2 in the right eye;the cell count could not be determined in the left eye. The patient was diagnosed with corneal endothelial dysfunction, bullous keratopathy, cataract, and secondary glaucoma. The patient was initially resistant to surgical intervention;however, he underwent artificial iris removal, cataract extraction, and corneal endothelial transplantation owing to symptom progression. The final visual outcomes were light perception and 0.01 in the right and left eyes, respectively, with severe visual field loss. The patient is currently receiving treatment to supportactivities of daily living at a low-vision clinic.

Conclusion:This case report illustrates the severe complications associated with cosmetic artificial iris implantation. Artificial iris implantation for cosmetic reasons should be contraindicated, given the significant risk of long-term visual impairment. Comprehensive risk information should be provided, and regular ophthalmological follow-ups and timely removal of the implants must be prioritized.


Copyright © 2025, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院

関連文献

もっと見る

文献を共有